Trade

with

Atossa Genetics Inc
(NASDAQ: ATOS)
AdChoices
1.16
+0.06
+5.45%
After Hours :
-
-
-

Open

1.14

Previous Close

1.10

Volume (Avg)

28.21k (303.66k)

Day's Range

1.10-1.17

52Wk Range

0.8000-3.28

Market Cap.

27.02M

Dividend Rate ( Yield )

-

Beta

-

Shares Outstanding

24.56M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 632.56k

    • Net Income

    • -10.78M

    • Market Cap.

    • 27.02M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -7,514.83

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -2.20

    • Price/Sales

    • 140.85

    • Price/Book Value

    • 1.48

    • Price/Cash flow

    • -2.17

      • EBITDA

      • -10.31M

      • Return on Capital %

      • -79.39

      • Return on Equity %

      • -89.38

      • Return on Assets %

      • -79.39

      • Book Value/Share

      • 0.74

      • Shares Outstanding

      • 24.56M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 5.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -97.00

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -31.07

            • 42.70

            • Pre-Tax Margin

            • -7,514.83

            • 11.63

            • Net Profit Margin

            • -7,514.83

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 9.39

              • 1.23

              • Quick Ratio

              • 9.18

              • 0.76

              • Interest Coverage

              • -5,406.70

              • 5.98

              • Leverage Ratio

              • 1.09

              • 2.16

              • Book Value/Share

              • 0.74

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.87

                • 33.44

                • P/E Ratio 5-Year High

                • -21.10

                • 325.07

                • P/E Ratio 5-Year Low

                • -1.36

                • 154.73

                • Price/Sales Ratio

                • 140.85

                • 2.32

                • Price/Book Value

                • 1.48

                • 3.05

                • Price/Cash Flow Ratio

                • -2.17

                • 19.05

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -89.38

                    (-)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • -79.39

                    (-)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • -89.36

                    (-)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • -

                  • 17.17k

                  • Inventory Turnover

                  • 108.29

                  • 5.07

                  • Asset Turnover

                  • 0.01

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -10.78M
                  Operating Margin
                  -1,704.93
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -2.17
                  Ownership

                  Institutional Ownership

                  2.46%

                  Top 10 Institutions

                  2.43%

                  Mutual Fund Ownership

                  2.03%

                  Float

                  80.34%

                  5% / Insider Ownership

                  2.19%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    272,217

                  • 0.00

                  • 1.11

                  • Vanguard Extended Market Index Fund

                  •  

                    126,889

                  • 38.22

                  • 0.52

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    64,731

                  • 0.00

                  • 0.26

                  • iShares Micro-Cap

                  •  

                    32,050

                  • 0.84

                  • 0.11

                  • Fidelity® NASDAQ Composite Index® Fund

                  •  

                    4,348

                  • 0.00

                  • 0.02

                  • AXA/Lord Abbett Micro Cap Portfolio

                  •  

                    3,045

                  • -16.37

                  • 0.01

                  • Fidelity Spartan® Total Market Idx Fund

                  •  

                    789

                  • 0.00

                  • 0.00

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Group, Inc.

                  •  

                    344,024

                  • +2.05%

                  • 1.41

                  • Geode Capital Management, LLC

                  •  

                    69,868

                  • 0.00%

                  • 0.28

                  • Knight Capital Americas LLC

                  •  

                    46,131

                  • +341.91%

                  • 0.19

                  • BlackRock Fund Advisors

                  •  

                    33,658

                  • +2.94%

                  • 0.14

                  • Goldman, Sachs & Co.

                  •  

                    27,773

                  • -30.68%

                  • 0.11

                  • Wells Fargo Advisors, LLC

                  •  

                    21,000

                  • +950.00%

                  • 0.09

                  • Northern Trust Investments, N.A.

                  •  

                    19,682

                  • 0.00%

                  • 0.08

                  • Pnc Bank, National Association

                  •  

                    13,975

                  • 0.00%

                  • 0.06

                  • Citigroup Inc

                  •  

                    3,412

                  • +2.22%

                  • 0.01

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Distressed

                  Style

                  -

                  Atossa Genetics Inc was incorporated in Delaware on April 2009. The Company is a healthcare company, engaged in the improvement of breast health through the development of a suite of laboratory developed tests (LDTs), FDA cleared med...moreical devices and therapeutics. Its laboratory tests are being developed by its subsidiary, The National Reference Laboratory for Breast Health, Inc. (the NRLBH), and are intended to address each of the four stages of the breast health care path: the cytological analysis of nipple aspirate fluid (NAF); the cytological analysis of ductal lavage fluid collected from each individual breast duct with its proprietary microcatheters; the profiling of newly diagnosed breast cancers through the determination of gene expression profiles in breast cancer biopsy tissue; and the moni...moretoring of breast cancer survivors for pre-clinical recurrence through a blood test for circulating tumor cells. The Company’s medical devices under development include the ForeCYTE Breast Aspirator (510(k) pending, not for sale in the United States) intended for the collection of NAF for cytological testing at a laboratory, intra ductal microcatheters for the collection of ductal lavage fluid and for the potential administration of a targeted therapeutic, and various tools for potential use by breast surgeons. It owns 137 issued patents (45 in the United States and at least 92 in foreign countries), and 11 pending patent applications (9 in the United States and 2 pending International Patent Cooperation Treaty (PCT) application) directed to its products, services, and technologies. The Federal Food, Drug, and Cosmetic Act, or FDCA, and the FDA’s implementing regulations, govern registration and listing, manufacturing, labeling, storage, advertising and promotion, sales and distribution, and post-market surveillance. Medical devices and the manufacturers are also subject to inspection by the FDA. The FDCA, supplemented by other federal and state laws, also provides civil and criminal penalties for violations of its provisions.lessless

                  Key People

                  Steven C. Quay,M.D.

                  CEO/Chairman of the Board/Director/President

                  Mr. Kyle Guse

                  CFO/Chief Accounting Officer/General Counsel/Secretary

                  Mr. Christopher S. Destro

                  Vice President, Divisional

                  Richard I. Steinhart

                  Director

                  Dr. Shu-Chih Chen

                  Director

                  • Atossa Genetics Inc

                  • 1616 Eastlake Ave. East

                  • Seattle, WA 98102

                  • USA.Map

                  • Phone: +1 800 351-3902

                  • Fax: +1 206 588-0256

                  • atossagenetics.com

                  Incorporated

                  2009

                  Employees

                  27

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: